Multidisciplinary approach to treatment of advanced gastric cancer
- Authors: Trusilova E.V.1, Besova N.S1, Khokhlova S.V1, Gorbunova V.A1, Nered S.N1, Stilidi I.S1
-
Affiliations:
- N.N. Blokhin Russian Cancer Research Center
- Issue: Vol 20, No 5 (2015)
- Pages: 33-36
- Section: Articles
- URL: https://journals.rcsi.science/1028-9984/article/view/40211
- DOI: https://doi.org/10.17816/onco40211
- ID: 40211
Cite item
Full Text
Abstract
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Elena V. Trusilova
N.N. Blokhin Russian Cancer Research Center
Email: tev_86@mail.ru
MD, PhD 115478, Moscow, Russian Federation
N. S Besova
N.N. Blokhin Russian Cancer Research Center115478, Moscow, Russian Federation
S. V Khokhlova
N.N. Blokhin Russian Cancer Research Center115478, Moscow, Russian Federation
V. A Gorbunova
N.N. Blokhin Russian Cancer Research Center115478, Moscow, Russian Federation
S. N Nered
N.N. Blokhin Russian Cancer Research Center115478, Moscow, Russian Federation
I. S Stilidi
N.N. Blokhin Russian Cancer Research Center115478, Moscow, Russian Federation
References
- Социально значимые заболевания населения России в 2013 году. М.; 2014.
- Ajani J.A., Moiseyenko V.M., Tjulandin S.A. et al. Quality of life with docetaxel plus cisplatin and fluorouracil compared with cisplatin and fluorouracil from a phase III trial for advanced gastric or gastroesophageal adenocarcinoma: the V-325 Study. J. Clin. Oncol. 2007; 25: 3210-6.
- Ajani J.A., Fodor M.B., Tjulandin S.A. et al. Phase II multiinstitutional randomized trial of docetaxel plus cisplatin with or without fluorouracil in patients with untreated, advanced gastric, or gastroesophageal adenocarcinoma. J. Clin. Oncol. 2005; 23(24): 5660-7.
- Van Cutsem E., Moiseyenko V.M., Tjulandin S., et al. Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: A report of the V325 Study Group. J. Clin. Oncol. 2006; 24: 4991-7.
- Gorbunova V., Orel N., Besova N. Combined chemotherapy with docetaxel in extensive advanced gastric cancer (pilot study). In: 10th International Congress on Anti-Cancer Treatment. Jan. 31-Feb. 3.2000. Paris; 2000: 270.
- Gorbunova V.A., Besova N.S., Orel F. et al. The efficacy and toxicity of Taxoter (T) + Cisplatin (P) + 5-FU (F) (TPF) as the first-line chemotherapy in advanced gastric cancer. Treatment possibilities in the elderly (aged 65 years). Final results. Ann. Oncol. 2004; 14 (Suppl. 3): III63, Abstr. 102.
- Трусилова Е.В., Бесова Н.С., Лимарева С.В., Багрова С.Г., Горбунова В.А., Бондаренко Ю.В. Эффективность и токсичность комбинированного режима доцетаксел + цисплатин + лейковорин + 5-фторурацил при диссеминированном раке желудка. Эффективная фармакотерапия. Онкология, гематология, радиология. 2013; 19(2): 5-12.
- Трусилова Е.В., Бесова Н.С., Лимарева С.В., Горбунова В.А., Неред С.Н., Стилиди И.С. Успешное комбинированное лечение больного диссеминированным раком желудка. Онкология. Журнал им. П.А. Герцена. 2013; 1: 51-3.
- Трусилова Е.В., Бесова Н.С., Багрова С.Г., Горбунова В.А., Стилиди И.С., Неред С.Н. Результаты комбинированного лечения больного диссеминированным раком желудка. Случай из практики. Вопросы онкологии. 2013; 1: 123-5.
- Orii T., Karasawa Y., Kitihara H. et al. Long-term survival after sequential chemotherapy and surgery for advanced gastric cancer. Int. J. Surg. Case Rep. 2013; 4(11): 976-80.
- Yano M., Shiozaki H., Inoue M. et al. Neoadjuvant chemotherapy followed by salvage surgery: effect on survival of patients with primary noncurative gastric cancer. World J. Surg. 2002; 26: 1155-9.